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Summary
Coronaviruses are causative agents of 
respiratory, gastrointestinal and neuro-
logical infections in mammals and birds. 
The main characteristic of coronaviruses 
is a high mutation rate, resulting in pos-
sible changes in their pathogenicity, tis-
sue tropism or in their host. Even though 
they have been known causes of disease 
for decades, they became interesting in 
the 21st century due to outbreaks of large 
epidemics in humans and causing serious 
economic losses in the animal production 
sector, primarily the pig industry. The out-
breaks of the highest concern emerged in 
2002 (Severe Acute Respiratory Syndrome 
‒ SARS) and in 2012 (Middle-East Respira-
tory Syndrome ‒ MERS). Both diseases are 
of animal origin, and manifested with se-
vere pneumonia in humans and a lethality 
of 11% and 36%, respectively. Today we 
are confronted with one of the largest ep-
idemics in the history of humankind, the 
COVID-19 pandemic. It is caused by a var-
iant of the SARS coronavirus and transmit-
ted through person to person contact, with 
no known animal vector. Until the time of 
press of this article the infection has been 
detected in over 4.8 million people and has 
been the cause of over 320,000 deaths. In 
Croatia, due to protective measures im-
posed by the National Civil Protection 
Headquarters, COVID-19 is still within lin-
ear case growth. This review provides in-
sight into known coronavirus infections in 
animals and humans and shows that novel 
coronaviruses have already marked the 21st 
century and likely changed the world, as 
we know it, forever.
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Introduction
Coronaviruses are the causative agents 
of mild to severe respiratory, gastrointes-
tinal and neurological infections in mam-
mals and birds. Most known coronavirus-
es have been detected in bats, swine and 
small mammals; however they can infect 
humans, horses, cattle, camels, cats, dogs, 
rats, birds, whales, minks, ferrets and 
other wild animals (Monchatre-Leroy 
et al., 2017). The main characteristic of 
coronaviruses is a high mutation rate, 
resulting in possible changes of their 
pathogenicity, tissue tropism or host, and 
therefore strain transmission has been 
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recorded amongst animal species, and 
from animals to humans. Though coro-
naviruses have been well known causes 
of infections for decades, they triggered 
scientific research worldwide in the 21st 
century due to epidemic outbreaks in 
both humans and animals caused by 
novel coronavirus strains. The most im-
portant public health infections recorded 
were the Severe Acute Respiratory Syn-
drome (SARS) in 2002, HKU1 (2003) and 
the Middle-East Respiratory Syndrome 
(MERS) in 2012. Today, we are confront-
ed with a pandemic, the Coronavirus in-
fectious disease 2019 (COVID-19) that is 
rapidly spreading globally and contribut-
ing to the development of infected, dis-
eased, socially vulnerable and economi-
cally deteriorated communities. 
Since 2000, there have been reports 
of novel coronavirus strains of higher 
virulence and pathogenicity spreading 
in animals, such as strains causing Pleu-
ral effusion disease in rabbits (2000), Ca-
nine respiratory coronavirus infection 
(2003), Porcine deltacoronavirus infec-
tion (2004), Equine coronavirus infection 
(2010), Swine acute diarrhoea syndrome 
(2016) and Porcine epidemic diarrhoea 
virus infection (2010, 2016). 
This review describes the main coro-
navirus characteristics, and the most im-
portant coronavirus infections in animals 
and humans that have already marked 
the 21st century, changing the world as 
we know it. 
Coronavirus aetiology
Coronaviruses belong to the realm Ri-
boviria, order Nidovirales, suborder Cornido-
virinae, family Coronaviridae, subfamily 
Orthocoronavirinae. The latter includes 
four genera: Alpha-, Beta-, Gamma- and 
Deltacoronavirus. The coronavirus origin 
is not well known; however, the mutual 
ancestor arose 8000 years BCE, while some 
evolution models estimate that the differ-
entiation of Orthocoronavirinae took place 
within the period from 3300 to 2400 BCE. 
Bats and birds are the main coronavirus 
reservoirs in the environment. Alpha- and 
betacoronaviruses are mostly found in 
bats, whereas delta- and gammacoronavi-
ruses are most common in birds (de Groot 
et al., 2011). 
Coronaviruses are pleomorphic, most-
ly spherical particles with a lipid bilayer 
envelope (Figure 1), approximately 120 
nm in diameter. The name refers to their 
common characteristic, the appearance 
of a ‘crown-like’ or corona-like forma-
tion of the spike or S-proteins emerging 
from the envelope, as seen under two-di-
mensional electron microscopy. Within 
the envelope, the helical capsid serves to 
protect the viral genome, one of the larg-
est (27-34 kb) known viral, single strand-
ed, positive sense RNA molecules. The 
first two-thirds of the molecule contain 
an open reading frame that encodes a 
replicase/transcriptase polyprotein that 
is post-translationally auto-cleaved into 
smaller non-structural proteins engaged in 
viral replication. The remaining open read-
ing frame (10 kb) of the coronavirus RNA 
encodes four structural proteins, the mem-
brane (M), envelope (E), spike (S) and nu-
cleocapsid (N) proteins (Fehr and Perlman, 
2015). The M-protein plays an important 
role in virion formation during replication 
and induces the synthesis of neutralizing 
antibodies and α-interferon (Nguyen and 
Hogue, 1997). The S-protein is a glycopro-
tein peplomer that recognizes and attaches 
to the complementary protein on the host 
cell. Therefore, the structure of the S-pro-
tein defines the tissue tropism of a corona-
virus. The majority of alphacoronaviruses 
attach to the aminopeptidaze N, located on 
the cell surfaces in the small intestine. The 
exception is strain NL63, which, like most 
known betacoronaviruses, attaches to the 
angiotensin-converting enzyme 2 (ACE2), 
located on the surface of cells primarily in 
the lungs, but also in the arteries, heart, kid-
ney, and intestines (Hofmann et al., 2005). 
On the other hand, the MERS coronavirus 
Coronaviruses – viruses marking the 21st century / Koronavirusi – virusi koji obilježavaju 21. stoljeće
VETERINARSKA STANICA 51 (3), 229–239, 2020. 231
is a betacoronavirus that attaches to dipep-
tidyl peptidase-4 receptors, a membrane 
glycoprotein of most human cells (Raj et 
al., 2013). Furthermore, S- protein induc-
es the synthesis of neutralizing antibodies 
and plays a role in viral replication in vitro 
and attenuation in vivo (Sato et al., 2011). 
The function of the E-protein is not fully 
understood; however, it is involved in the 
formation of the virion during replica-
tion and exocytosis (Ruch and Macham-
er, 2012). The N-protein protects the viral 
RNA in the environment and is connected 
to the RNA in a helical complex that facil-
itates RNA release after entering the host 
cell (Sturman et al., 1980). Most betacoro-
naviruses contain an additional protein on 
their surface, hemagglutinin esterase (HE), 
which enables their attachment to sialic 
acid on host cells receptors. HE enhances 
neurovirulence in several betacoronavirus 
strains, such as certain strains of murine 
hepatitis coronavirus (Kazi et al., 2005; de 




Bovine coronavirus (BCV) is a 
member of the betacoronavirus genus. 
It was recognized as a causative agent 
of cattle infections in the late 18th cen-
tury, following its differentiation from 
equine coronaviruses. It is responsible 
for causing severe enteritis in calves 
one week to three months of age, and it 
also participates in the development of 
enzootic pneumonia in calves and win-
ter dysentery in cattle. Wild bovines are 
also susceptible to infections caused by 
BCV (Haitham, 2018). The infection can 
be transmitted horizontally, or via the 
faecal-oral or respiratory routes. A vac-
cine is commercially available and vac-
cination of gravid cows and heifers is 
recommended to prevent the disease in 
newborn calves. BCV has been report-
ed in cattle in Croatia and has incurred 
significant economic losses in the cattle 
industry (Lojkić et al., 2009, 2015).
Swine
Swine have proven to be optimal 
‘incubators’ for coronaviruses and the 
21st century has already been marked 
by novel strains and genotypes that 
have resulted in the death of millions 
of swine worldwide, seriously affecting 
the pig industry. Coronaviruses in swine 
primarily cause gastrointestinal disor-
ders that may have a lethal outcome, 
especially in piglets. Most infections are 
Figure 1.  SARS CoV-2 projected by electron microscopy by the Center for Disease Control and Pre-
vention, CDC (Ecker & Higgins, USA) and a schematic presentation of the coronavirus cross 
section (http://www.ph.ucla.edu/epi/bioter/graphics/sars_holmes2003.jpg).
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caused by alphacoronaviruses. The first 
was described in 1943 and was named 
Transmissible gastroenteritis of swine 
(TGE). All age groups can be affected, 
however the most susceptible are pig-
lets with a lethality of almost 100%. In 
recent decades, the infection has been 
sporadic and the last case in Croatia 
was reported in 1972. The decrease in 
the number of outbreaks may be the re-
sult of the appearance of a novel coro-
navirus in 1986, the Porcine respiratory 
coronavirus (PRC). PRC coronavirus 
has a lower virulence and pathogenicity 
and is antigenetically closely related to 
the TGE coronavirus, therefore it is pos-
sible that its global spread induced the 
synthesis of antibodies that ensure im-
munity against both viruses. The main 
difference between the TGE and PRV 
coronaviruses is within the genome re-
gion encoding the S-protein, resulting 
in differences in tissue affinity. During 
the 1970s, a new coronavirus was de-
scribed in Europe: Porcine epidemic 
diarrhea virus (PEDV). It caused clin-
ical disorders similar to those resulting 
from TGE infection. Despite its global 
spread, until the appearance of a novel 
and highly pathogenic strain in China 
(2010), USA (2013) and Europe (2014), 
it did not arouse broader scientific in-
terest (Wang et al., 2019). It was also re-
corded in Croatia in 2016 (Brnić et al., 
2019, 2020). Implementation of strict 
biosecurity measures and vaccination 
with commercially available vaccines 
halted the spread of the infection. How-
ever, this did not end the occurrence 
of new coronaviruses in swine. During 
2016, a new coronavirus was described 
in China as the causative agent of Swine 
acute diarrhoea syndrome (SADS-
CoV), which had a lethality outcome of 
90% (Wang et al., 2019). 
Swine are also susceptible to infec-
tions with beta- and deltacoronavirus-
es. One of the longest known infections 
of animals caused by a coronavirus is 
the Porcine hemagglutinating enceph-
alomyelitis infection (PHE), which 
causes gastrointestinal disorders, and 
symptoms of the central nervous sys-
tem. It was first described in 1957 and is 
still present in the pig industry today, 
primarily on farms with low biosecuri-
ty measures. The most recent outbreaks 
were recorded in 2001 and 2002 in Can-
ada and 2006 in Argentina (Mora-Díaz 
et al., 2019). Porcine deltacoronavirus 
infection (PDI) is caused by a novel 
coronavirus strain described in Asia 
in 2009. Its effect on swine health was 
identified in 2014 in the USA when it 
was recognized as the cause of signifi-
cant losses in the pig industry. Current-
ly, it has been recorded in Asia, North 
America and Mexico (Wang et al., 2019). 
According to evolutionary parameters, 
it was transmitted from songbirds (Pas-
seriformes) to swine, likely due to RNA 
recombination (Zhang et al., 2016). 
The susceptibility of birds towards the 
virus was confirmed by a successful 
challenge infection of Specific-Patho-
gen-Free (SPF) chicks. Even though PDI 
does not have a high lethality rate (less 
than 50%), due to its partial genome 
analogy with strains derived from hu-
mans, pigs and birds, its zoonotic po-
tential and possibility of host change 
cannot be excluded (Jung et al., 2015). 
Poultry
The first gammacoronavirus infec-
tion in poultry, Infectious bronchitis in 
poultry (IBR), was described in chick-
ens in 1931. The infection causes patho-
logical changes within the upper res-
piratory tract and the epithelium of the 
oviduct, resulting in a rapid decrease 
of egg production (up to 70%). Some 
strains are nephropathogenic causing 
severe kidney disease accompanied 
by high lethality rates. The severity of 
the disease depends on the viral strain, 
ambient temperature, and the age, im-
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mune status and general condition of 
chickens. Lethality ranges from 5% to 
60%, depending on the occurrence of 
secondary bacterial infections. IBR is 
spread worldwide and is prevented by 
vaccination. However, due to the high 
mutation rate of the virus, and anti-
gen variations, the efficacy of vaccina-
tion depends on the compatibility of 
the vaccine strain used (Jackwood and 
de Wit, 2019). At the end of the 1940s, 
a gammacoronavirus infection in tur-
keys (TCoV) was described in the USA. 
It was manifested by symptoms of acute 
atrophic enteritis, such as watery diar-
rhoea, inappetence and death (5 – 50%). 
It is also spread in Canada, Europe 
and Brazil, where it causes sporadic 
outbreaks that have been increasing in 
recent decades. Phylogenetic analysis 
has shown that TCoV has differenti-
ated from the IBR coronavirus due to 
a recombination of the S-protein gene 
(Chen et al., 2015). 
Cats
Feline coronavirus (FCoV) belongs 
to the alphacoronavirus genus and 
causes predominantly mild gastrointes-
tinal infections in cats. It is spread via 
the faecal-oral route, and can remain 
infective in the environment. Therefore, 
most cats that are not kept indoors will 
be exposed to the virus sooner or lat-
er during their lifetime, though only 
a small number will actually develop 
symptoms of the disease. FCoV has a 
high mutation rate and in areas with a 
high density of cats, the occurrence of 
RNA recombination is more frequent. 
The most known FCoV ‘mutant’ caus-
es feline infectious peritonitis (FIV), a 
fatal disease of domestic and wild cats 
of all ages, even though the most sensi-
tive to the infection are young cats up to 
three years of age. The disease can have 
an effusive (wet) or non-effusive (dry) 
form. The acute, wet form is character-
ized by breathing disorders and symp-
toms followed by the development of 
ascites, while the chronic, dry form 
lacks specific signs of disease, but is 
followed by general signs of infection, 
loss of sight and neurological disorders. 
The infection has been known from the 
1950s but was officially reported in 1963 
(Holzworth, 1963). FIV was described in 
Croatia in the 1970s and is still present 
among cats today (Hađina et al., 2015).
Dogs
Canine coronaviruses belong to dif-
ferent genera and vary in their proper-
ties, especially virulence. Canine coro-
navirus enteritis (CCoV1) is caused 
by an alphacoronavirus that shows a 
tropism towards the epithelium of the 
small intestine, especially in puppies. 
The infection is mostly mild, even sub-
clinical, and it spreads through the fae-
cal-oral route. It was recorded in 1972 
in Germany, and today is spread world-
wide. A vaccine is commercially availa-
ble for the prevention of the disease. Ca-
nine respiratory coronavirus (CCoV2) 
was detected in Great Britain in 2003 as 
the cause of respiratory infections pri-
marily described in puppies as ‘kennel 
cough'. Currently, it is globally wide-
spread. Phylogenetical analysis showed 
that the causative agent is a betacorona-
virus that is genetically highly related 
(98.8%) to the bovine coronavirus and 
the human coronavirus strain OC43 
(98.4%). Its relationship with CCoV1 is 
much lower (68.53%) (Erles et al., 2003). 
Horses
Equine coronavirus (ECoV) belongs 
to the betacoronavirus genus and was 
described in 2010 in two-year-old hors-
es showing general clinical signs of in-
fection, gastrointestinal disorders, and 
neurological features. It is now known 
that the infection has a mild course and 
that all age categories of equines can be 
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affected. The disease has been reported 
in the USA, Japan and Europe (Pusterla 
et al., 2013). 
Rabbits
Rabbit enteric coronavirus infection 
was described in the 1980s in rabbits 
six to eight weeks of age. The infection 
has a mild course and primarily affects 
the gastrointestinal tract. A more se-
vere coronavirus disease in laboratory 
rabbits is Pleural effusion disease. The 
target organ of the virus is the heart, re-
sulting in cardiomyopathic changes. It 
is assumed that the virus, an alphacoro-
navirus, was introduced iatrogenical-
ly into laboratories. Recently, a novel 
betacoronavirus has been detected in 
rabbits in China (Lau et al., 2012).
Murines
Murine coronavirus is a betacoro-
navirus (MCoV) that causes primarily 
hepatitis characterized by a high mor-
tality rate in mice. Some strains may 
lead to progressive demyelinating en-
cephalitis in laboratory mice. MCoV has 
been used as a model for coronavirus 
pathogenicity research and studies on 
viral replication. In human medicine, it 
has been used for decades as a model 
for multiple sclerosis research (Tirotta 
et al., 2010).
Coronavirus infections in 
humans
Coronaviruses were first isolated 
from humans in the 1950s. Since then, 
they have caused mild infections of the 
upper or lower respiratory tract, with a 
seasonal character predominant in win-
ter and early spring. The first described 
coronavirus in humans was strain 
OC43 of the betacoronavirus genus. 
The strain is genetically highly related 
to bovine coronavirus. Currently, four 
genotypes have been recognized, the 
original genotype A, genotypes B and 
C that differentiated in the 1980s, and 
genotype D that developed in the 1990s 
as a result of recombination of gen-
otypes B and C. At the turn of the 21st 
century, a novel betacoronavirus was 
isolated from humans ‒ strain HKU1, 
the cause of bronchitis that in some cas-
es can lead to pneumonia. HKU1 was 
isolated from a patient in Hong Kong 
in 2005, though further investigation 
found the virus in an archive sample 
from a patient with severe pneumonia 
in 2003 (Lau et al., 2006). HKU1 was 
also detected in the USA where it was 
named HCoV-NH (New Haven), and in 
Europe (Esper et al., 2006). Phylogenet-
ic analysis has shown high genetic re-
lation with the murine coronavirus. Ex-
cept betacoronaviruses, common colds 
in humans can also be the result of al-
phacoronavirus infections. The most 
frequent strain of the common cold is 
strain 229E, which is also derived from 
bats. In addition to mild respiratory 
infections, 229E can cause pneumonia. 
A similar pathogenicity has been ob-
served in strain NL63. Recent research 
has shown a connection of strain NL63 
with hoarseness and even Kawasaki 
disease in children (Fielding, 2011). 
SARS
In 2002, a respiratory infection in 
humans was described in China that 
then spread throughout Eastern Asia 
(Chan-Yeung and Xu, 2003). Cases of 
the disease were subsequently report-
ed in Canada (Toronto) and USA (New 
York, San Francisco). The causative 
agent of the disease was a betacoronavi-
rus, SARS CoV-1. During the epidemic, 
8442 people were infected with a fatal 
outcome in 916 cases (11%). Patients 
over the age of 50 years proved to be 
more susceptible to infection, where-
as those under 30 years of age were 
more resistant. In June 2003, the World 
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Health Organization (WHO) declared 
the end of the epidemic. However, sev-
eral sporadic cases of SARS caused by 
SARS CoV-1-like viruses have been 
reported since. The natural reservoir 
of the virus was found to be the horse-
shoe bat (Rhinolophidae). However, the 
virus was transmitted to humans by the 
Asian palm civet (Paradoxurus hermaph-
roditus). Retrospectively, SARS CoV-1 
was isolated from raccoon dogs (Nyc-
tereuteus sp.), ferrets (Melogale spp.) 
and domestic cats (Lau et al., 2006). The 
virus attaches to the ACE2 receptors of 
host cells, mainly the alveolar type II 
cells of the lungs, though it can also be 
detected in the epithelium of arteries, 
in the heart, kidney and small intestine. 
SARS is characterized by the develop-
ment of fibrinous pneumonia, possible 
osteoporosis and femoral necrosis, with 
clinical manifestation similar to influ-
enza. The incubation is four to six days, 
rarely one and a maximum of 14 days. 
The rapid disappearance of the disease 
astonished epidemiologists worldwide. 
Even so, SARS revealed the possibility 
of the appearance of novel strains of 
coronaviruses that may threaten all hu-
manity. 
MERS 
MERS was recorded in Saudi Arabia 
in 2012, after which it spread through-
out the Arabian Peninsula. It was also 
diagnosed in people travelling from the 
Arabian Peninsula to the USA, Africa, 
Europe and Asia (Zumla et al., 2015). 
The causative agent of the disease was 
discovered to be a betacoronavirus 
(MERS CoV). Nowadays, the virus is 
divided into two groups, the first isolat-
ed strains belong to group A, whereas 
novel strains belong to group B (Chu et 
al., 2014). MERS CoV is not genetically 
highly related to SARS CoV-1, though 
it shows high genetical analogy with 
strains isolated from bats, indicating 
they are its natural reservoirs. Further 
research showed that the Arabian cam-
el (Camelus dromedarius) was the source 
of infection for humans, even though 
the transmission route from camels to 
humans is still unknown. MERS CoV 
in camels causes the ‘camel flu’. In hu-
mans, MERS is manifested by severe 
respiratory disorders, with a fatal out-
come in one-third (36%) of infected pa-
tients. According to the available data, 
2468 people were infected by MERS 
CoV, with 851 deaths (WHO, 2019). 
Less frequently, gastrointestinal disor-
ders can also appear. Horizontal trans-
mission (person to person) is very rare 
and is reported as a hospital acquired 
infection (Assiri et al., 2013). The lack of 
human transmission of MERS limits the 
spread of disease, and therefore MERS 
is not on the list of viral diseases that 
can threaten humanity. Currently, there 
are no available vaccines against SARS 
or MERS. 
COVID-19
COVID-19 is a respiratory infection 
of humans caused by the betacoronavi-
rus SARS CoV-2, a variant of the strain 
SARS CoV-1 (Zhu et al., 2020). The main 
reservoir of the virus is the bat, though 
no animal species have yet been recog-
nized as the intermediate transmitter of 
SARS CoV-2 to humans. After the first 
report of the disease in Wuhan, China in 
December 2019, the WHO pronounced 
COVID-19 a Public Health Emergen-
cy of International Concern, and pro-
nounced a pandemic on 11th of March 
2020. At the time of press of this article, 
officially over 4.8 million people have 
been infected by SARS CoV-2, with an 
average lethality rate of 6.7%. The sever-
ity of the disease and its outcome largely 
varies depending on patient age, general 
condition and the presence of risk fac-
tors (hypertension, diabetes and heart 
diseases). Younger people are more re-
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silient to infection, whereas in patients 
over 70 years of age, lethality increases 
up to 15% (Hui et al., 2020). SARS CoV-2 
is easily transmitted from person to per-
son, mostly due to aerosols and droplets 
released by coughing, and can also be 
transmitted indirectly through contact 
with contaminated materials and sur-
faces. The virus remains infective on 
copper surfaces for 18, cardboard for 55, 
stainless steel for 90 and plastic for 100 
hours (van Doremalen et al., 2020). SARS 
CoV-2 has been detected in faeces in 54% 
of patients during the course of the dis-
ease, as well as in reconvalescents even 
after the virus is no longer detected in 
the nasopharyngeal mucosa, indicating 
the possibility of faecal-oral spread (Gu 
et al., 2020). Vertical transmission has 
not been confirmed (Chen et al., 2020). 
The incubation of COVID-19 is five to six 
days, maximum 14 days, though most 
subjects (97%) develop signs of the dis-
ease as late as 11.5 days post infection. 
About 20% of infected subjects will show 
no signs of the disease but are consid-
ered important carriers/transmitters (Bai 
et al., 2020). High population density in 
small areas, closed rooms, and public 
transport are considered risk factors of 
viral transmission. Therefore, personal 
protection measures (hand and body hy-
giene, required distances, auto-isolation, 
working from home, masks, etc.) and 
public protection measures (bans of so-
cial gatherings, public transport, closing 
schools and kindergartens, cancelling 
cultural events, intercity transport, etc.) 
are highly recommended and imple-
mented. The aim is to flatten the epidem-
ic curve as much as possible to prevent a 
rapid increase of the number of infected 
persons and their contacts in a limited 
timeframe. Only by constraining move-
ment will viral transmission be reduced 
from R0=2.35 to R0=1.05 (Kucharski et 
al., 2020).
Clinically, COVID-19 is similar to 
influenza, accompanied by gastroin-
testinal and cardiovascular disorders. 
Other symptoms, such as anosmia, 
have been reported (Iacobucci, 2020). 
Severe cases describe laboured breath-
ing, chest pain and hypoxia. Spontane-
ous coagulation disorders and cytokine 
storm can occur. Following progressive 
pneumonia, acute respiratory distress 
syndrome (ARDS) and multi-organ fail-
ure can arise, resulting in death (Hui et 
al., 2020). The seroconversion dynam-
ics have not yet been fully elucidated, 
though a challenge infection and re-in-
fection in Macaque monkeys resulted 
in the occurrence of active immunity. 
COVID-19 diagnosis is based on the 
epidemic situation, clinical signs, X-ray 
and CT scans, blood testing and detec-
tion of the viral RNA in nasopharyn-
geal swabs by Reverse Transcription 
Polymerase Chain Reaction (PCR) 
methodology. The recommended meth-
ods for diagnosing are real time PCR 
protocols (Centers for disease control 
and prevention, CDC, 2020). Recent-
ly, quick tests for detecting COVID-19 
have been approved by WHO. Commer-
cially available serological tests have 
also been developed. Previously, there 
were no specific prevention methods or 
therapies listed for COVID-19. Even if 
a vaccine were to be developed soon, 
its active administration would not be 
possible before 2021. However, extreme 
scientific capacities are involved in in-
vestigating different models of inacti-
vated and genetically modified vaccines 
based primarily on the S-protein. Due 
to the lack of an effective vaccine, the 
focus of current scientific research is in-
vestigating known or novel chemother-
apeutics for treating the disease. Four 
have already been used in clinical trials: 
remdesivir (nucleotide analogue used 
for Ebola, Marlburg fever, SARS and 
MERS), chloroquine and hydroxychlo-
roquine (anti-malarial drugs), lopina-
vir/ritonavir (anti-HIV treatment) and 
lopinavir/ritonavir combined with β-in-
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terferon (Kupferschmidt and Cohen, 
2020). Recently, ACE2 receptor inhibi-
tors are being investigated for the pre-
vention or treatment of COVID-19. An-
other option investigated is the use of 
passive immunization by convalescent 
sera that showed good results in SARS 
treatment. 
To date, there has been no evidence 
of SARS CoV-2 naturally infecting an-
imals; however, ACE2 receptors with 
similar configuration as human ACE2 
receptors are found in some animal spe-
cies, theoretically raising the question of 
possible susceptibility (Wan et al., 2020). 
This hypothesis should be challenged, 
since SARS CoV-2 RNA was detected in 
two dogs in Hong Kong, a cat in Belgium 
and a tiger from a zoo in New York. The 
owners of the dogs and cat, and the tiger 
trainer all tested positive for SARS CoV-
2 (WHO, 2020). Therefore, even though 
no reasonable connection was found, a 
thorough investigation of animals as 
potential virus carriers is needed. Until 
then, COVID-19 positive owners of an-
imals should be cautious because they 
can transmit SARS CoV-2 to their pets or 
contaminate them. Due to the initiative 
of the Croatian Ministry of Agriculture, 
Directorate for Animal Health and Food 
Safety, in collaboration with the Croa-
tian Veterinary Institute and Veterinary 
Faculty, University of Zagreb, an Action 
Plan has been developed to ensure pre-
paredness in case testing of animals is 
needed. 
COVID-19 has altered our compre-
hension of society in general. Countries 
that have been struck by the disease 
have reported the appearance of xeno-
phobia, coronophobia, depression and 
despair due to loneliness and the feel-
ing of hopelessness. COVID-19 has also 
negatively impacted the economy. The 
consequences of the pandemic will be 
calculated and visible only after it ends. 
In conclusion, coronavirus infections, 
especially COVID-19, have changed the 
perception of life and the world marking 
the 21st century, forever. 
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Koronavirusi su uzročnici respiratornih, 
gastrointestinalnih i neuroloških infekcija u 
sisavaca i ptica. Značajka je koronavirusa vi-
soka mutacijska stopa koja može rezultirati 
promjenom patogenosti, tkivnog tropizma 
i/ili domaćina. Premda su znanstvenoj jav-
nosti poznati već desetljećima, potakli su 
posebno zanimanje istraživača tek u 21. sto-
ljeću nakon pojave emergentnih koronaviru-
snih infekcija epidemijskih razmjera u ljudi, 
ali i životinja, naročito svinja. Najznačajnije 
su emergentne infekcije u ljudi teški akutni 
respiratorni sindrom (SARS) koji je obilježio 
2002. godinu i srednje-istočni respiratorni 
sindrom (MERS) koji se pojavio 2012. godi-
ne. Obje su infekcije životinjskog podrijetla, 
a očituju se teškom pneumonijom u ljudi s 
letalitetom od 11 % (SARS) i 36 % (MERS). 
Danas smo suočeni s jednom od najvećih 
epidemija u povijesti čovječanstva, pande-
mijom COVID-19. Uzročnik je koronavirus, 
inačica virusa uzročnika SARS, a prenosi se 
izravno s čovjeka na čovjeka. Nije poznato je 
li u transmisiji virusa na ljude sudjelovala i 
životinja. Do dana tiskanja ovog članka je in-
fekcija ustvrđena u više od 4,8 milijuna ljudi 
sa smrtnim ishodom u preko 320 000 ljudi. 
U Hrvatskoj je zahvaljujući Nacionalnom 
stožeru civilne zaštite za COVID-19 i mjera-
ma koji je stožer preporučio i uveo, infekcija 
još uvijek u granicama mogućnosti pružanja 
potrebite skrbi. Ovaj članak opisuje korona-
virusne infekcije u životinja i ljudi te prika-
zuje kako su novi sojevi koronavirusa već 
sada obilježili 21. stoljeće i možda zauvijek 
promijenili svijet.
Ključne riječi: koronavirusi, životinje, ljudi, 
COVID-19
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